Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Holders of 5% or more of INO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Inovio Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G | 14.80%9.85M shares | New | Dec 5, 20251 filing | Dec 5, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 9.99%6.67M shares | +3.79 ppfrom 6.20% | Nov 14, 20252 filings | Dec 8, 2025 | SEC |
| Highbridge Capital Management LLC | 13G | 9.20%3.63M shares | New | Feb 10, 20251 filing | Feb 10, 2025 | SEC |
| Vanguard Group Inc | 13G | 5.53%2.03M shares | +0.89 ppfrom 4.64% | Jan 30, 20252 filings | Apr 30, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Inovio Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 8, 202511:45 AM ET | Janus Henderson Group PLC | 13G/A | 9.99%6.67M shares | +3.79 ppfrom 6.20% | Nov 28, 2025 | SEC |
| Dec 5, 20252:03 PM ET | FMR LLCand 1 other | 13G | 14.80%9.85M shares | New | Nov 28, 2025 | SEC |
| Nov 14, 202510:34 AM ET | Janus Henderson Group PLCand 1 other | 13G | 6.20%3.27M shares | New | Sep 30, 2025 | SEC |
| Jul 17, 20257:54 PM ET | BlackRock, Inc. | 13G/A | 1.50%537.6K shares | −4.80 ppfrom 6.30%Below 5% | Jun 30, 2025 | SEC |
| May 14, 20254:10 PM ET | Stonepine Capital Management, LLCand 3 others | 13G/A | 3.80%1.43M shares | −1.40 ppfrom 5.20%Below 5% | Mar 31, 2025 | SEC |
| Apr 30, 202511:24 AM ET | Vanguard Group Inc | 13G | 5.53%2.03M shares | +0.89 ppfrom 4.64% | Mar 31, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 6.30%2.32M shares | +1.00 ppfrom 5.30% | Mar 31, 2025 | SEC |
| Feb 10, 20255:06 PM ET | Highbridge Capital Management LLC | 13G | 9.20%3.63M shares | New | Dec 31, 2024 | SEC |
| Feb 5, 20255:28 PM ET | BlackRock, Inc. | 13G/A | 5.30%1.91M shares | – | Dec 31, 2024 | SEC |
| Jan 30, 20259:58 PM ET | Vanguard Group Inc | 13G/A | 4.64%1.67M shares | –Below 5% | Dec 31, 2024 | SEC |
| Dec 23, 20248:08 PM ET | Stonepine Capital Management, LLCand 3 others | 13G | 5.20%1.92M shares | New | Dec 17, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Inovio Pharmaceuticals, Inc. shares.
No Form 144 notices for Inovio Pharmaceuticals, Inc. are on file.